Related Experiment Video
Updated: Apr 20, 2026
15:03
Building a Better Mosquito: Identifying the Genes Enabling Malaria and Dengue Fever Resistance in A. gambiae and A. aegypti Mosquitoes
Published on: July 4, 2007
11.5K
Mosquito Akirin as a potential antigen for malaria control
Mário da Costa, Renato Pinheiro-Silva, Sandra Antunes
1Instituto de Higiene e Medicina Tropical, Rua da Junqueira 100, 1349-008 Lisbon, Portugal. adomingos@ihmt.unl.pt.
Malaria Journal
|December 5, 2014
Summary
Akirin (AKR) vaccination reduced malaria parasite infection in mosquitoes, suggesting AKR-based vaccines could aid in controlling this deadly vector-borne disease. Further field studies are needed to confirm efficacy in natural settings.
Area of Science:
- Vector-borne disease control
- Parasitology
- Immunology
Background:
- Vector-borne diseases pose significant threats to global human and animal health.
- Malaria, a deadly disease caused by Plasmodium parasites, is transmitted by Anopheles mosquitoes.
- Previous studies indicated Subolesin (SUB) and Akirin (AKR) vaccines could reduce vector fitness and pathogen infection.
Purpose of the Study:
- To investigate the role of Akirin (AKR) in Plasmodium berghei infection.
- To assess the impact of AKR on the fitness and reproduction of the malaria vector Anopheles gambiae.
Main Methods:
- Gene knockdown of akr in Anopheles gambiae using RNA interference.
- Vaccination of mice with recombinant Aedes albopictus AKR.
- Assessing parasite infection, mosquito fertility, and mortality rates.
Main Results:
- RNA interference targeting akr suggested a role in mosquito survival and fertility.
- Vaccination with recombinant AKR significantly reduced Plasmodium infection in mosquitoes fed on immunized mice.
- Control groups showed higher infection rates compared to AKR-vaccinated groups.
Conclusions:
- Recombinant AKR holds potential for developing novel malaria control vaccines.
- AKR-based vaccines could be utilized in wildlife reservoirs or humans to decrease pathogen transmission.
- Field trials are essential to validate the effectiveness of AKR vaccines on vector populations and disease transmission.
